Invention Grant
US08153160B2 Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
失效
包含硝苯地平和/或尼索地平的活性成分组合和血管紧张素II拮抗剂的药物剂型
- Patent Title: Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
- Patent Title (中): 包含硝苯地平和/或尼索地平的活性成分组合和血管紧张素II拮抗剂的药物剂型
-
Application No.: US11922745Application Date: 2006-06-29
-
Publication No.: US08153160B2Publication Date: 2012-04-10
- Inventor: Andreas Ohm , Klaus Benke , Hanna Tinel , Joachim Hütter
- Applicant: Andreas Ohm , Klaus Benke , Hanna Tinel , Joachim Hütter
- Applicant Address: DE Berlin
- Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee Address: DE Berlin
- Agent Karen B. King
- Priority: DE102005031577 20050706
- International Application: PCT/EP2006/006293 WO 20060629
- International Announcement: WO2007/003330 WO 20070111
- Main IPC: A61K9/16
- IPC: A61K9/16
Abstract:
The present invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine and/or nisoldipine and at least one angiotensin II antagonist, characterized in that the active ingredient combination undergoes controlled (modified) release in the body, and to processes for the production thereof, to the use thereof as pharmaceuticals, to the use thereof for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and to the use thereof for manufacturing a pharmaceutical for the prophylaxis, secondary prophylaxis and/or treatment of disorders.
Public/Granted literature
Information query
